Skip to main content
Premium Trial:

Request an Annual Quote

Cytoo, Cellectis Bioresearch, CEA Receive $10.2M to Develop Cell-based Assays

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French life science firm Cytoo announced today that it, Cellectis Bioresearch, and the French Alternative Energies and Atomic Energy Commission (CEA) are partnering to develop cell-based assays for drug development and toxicology.

The project, called ETICS, for Evolved Tissue Inspired Cell Systems, is being funded with €7.6 million ($10.2 million) over five years from OSEO, a French agency that provides funding to small- and medium-sized firms. Cytoo is receiving €4 million for the project, Cellectis Bioresearch is being provided €2.9 million, and CEA is getting €700,000.

ETICS is directed at the development of cell-based assays, to be sold as kits made up of genetically modified cells by Cellectis Bioresearch and micropatterned supports from Cytoo.

"By controlling the expression, the architecture, and the 2D and 3D environment of the cells, thus mimicking in vivo conditions of the tissue they derive from … these assays will have much higher relevance to discover better and safer drugs," Cytoo said in a statement.

According to the firm, the project could generate more than €600 million for the consortium in a decade.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.